Literature DB >> 6299203

Two anatomoclinical types of warts with plantar localization: specific cytopathogenic effects of papillomavirus. Type I (HPV-1) and type 2 (HPV-2).

R Laurent, J L Kienzler, O Croissant, G Orth.   

Abstract

In this study, the clinical and histopathological aspects of 50 plantar warts are reported in relation to the type of papillomavirus present in the lesions, as detected by immunofluorescence tests, using specific guinea pig fluorescein-labelled IgG. Warts of plantar localization are not caused by the same human papillomavirus (HPV) since they are found to be associated with both HPV type 1 (HPV-1) and HPV type 2 (HPV-2). HPV-1 is always associated with deep and painful plantar warts (myrmecia), whereas HPV-2 is found to be associated with superficial, painless plantar warts (vulgaris or often mosaic type). Histologically, these two types of plantar warts are quite different. In myrmecia (HPV-1), characterized by an endophytic growth, large eosinophilic, keratohyaline-like granules are observed in the cytoplasm and nucleus of infected, often vacuolated cells. These granules appear early in stratum spinosum and are very numerous in stratum granulosum. In the mosaic type (HPV-2), the histopathological aspect is not different from that of common warts; these lesions have an exophytic growth and are characterized by foci of clear vacuolized cells which are found in stratum granulosum. Their cytoplasm contains round, basophilic keratohyalin granules which often have a heterogenous aspect. These differences are observed in other localizations of morphologically related warts associated with HPV-1 and HPV-2 and seem to be related to a specific cytopathogenic effect of HPV-1 an HPV-2 in human papillomas.

Entities:  

Mesh:

Year:  1982        PMID: 6299203     DOI: 10.1007/bf00510364

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  21 in total

1.  Electron microscope study of human warts; sites of virus production and nature of the inclusion bodies.

Authors:  J D ALMEIDA; A F HOWATSON; M G WILLIAMS
Journal:  J Invest Dermatol       Date:  1962-06       Impact factor: 8.551

2.  The myrmecia; a study of inclusion bodies in warts.

Authors:  A LYELL; J A R MILES
Journal:  Br Med J       Date:  1951-04-28

3.  Seroepidemiological studies of human papilloma virus (HPV-1) infections.

Authors:  H Pfister; H zur Hausen
Journal:  Int J Cancer       Date:  1978-02-15       Impact factor: 7.396

Review 4.  The human papillomaviruses.

Authors:  G Orth; S Jablonska; F Breitburd; M Favre; O Croissant
Journal:  Bull Cancer       Date:  1978       Impact factor: 1.276

5.  [Light-microscopic study of classified virus warts (HPV-1 and HPV-4) (author's transl)].

Authors:  E I Grussendorf
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

6.  Anogenital warts contain several distinct species of human papillomavirus.

Authors:  R A Krzyzek; S L Watts; D L Anderson; A J Faras; F Pass
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

7.  Identification of papillomaviruses in butchers' warts.

Authors:  G Orth; S Jablonska; M Favre; O Croissant; S Obalek; M Jarzabek-Chorzelska; N Jibard
Journal:  J Invest Dermatol       Date:  1981-02       Impact factor: 8.551

8.  Characterization of a new type of human papillomavirus that causes skin warts.

Authors:  G Orth; M Favre; O Croissant
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

9.  [Human papilloma viruses (author's transl)].

Authors:  H zur Hausen
Journal:  Arzneimittelforschung       Date:  1977-01

10.  [Comparison of the epidermodysplasia verruciformis Lewandowsky-Lutz with the other Papova virus acanthomas by light and electron microscopy (author's transl)].

Authors:  J Kaufmann; C Meves; F Ott
Journal:  Arch Dermatol Res       Date:  1978-02-15       Impact factor: 3.017

View more
  3 in total

1.  Identification of nuclear and cytoplasmic proteins that interact specifically with an AU-rich, cis-acting inhibitory sequence in the 3' untranslated region of human papillomavirus type 1 late mRNAs.

Authors:  C Zhao; W Tan; M Sokolowski; S Schwartz
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

2.  Comparative investigation of epidermal markers on cells freshly isolated from from normal and wart epidermis.

Authors:  Y Chardonnet; J Viac; P Beauve; J Thivolet
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

3.  Life cycle heterogeneity in animal models of human papillomavirus-associated disease.

Authors:  Woei Ling Peh; Kate Middleton; Neil Christensen; Philip Nicholls; Kiyofumi Egawa; Karl Sotlar; Janet Brandsma; Alan Percival; Jon Lewis; Wen Jun Liu; John Doorbar
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.